Phase 2 Migraine Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 80 who have a clinic visit at Stanford Pain & ENT clinic and whose main complaint is a craniofacial (head and face) pain condition, such as migraine, cluster headache, trigeminal autonomic cephalgia, sphenopalatine ganglioneuralgia, or paroxysmal hemicrania (confirm with trial site if unsure which category applies)
Who may not be able to join:
- People under 18 or over 80 years of age
- People who are pregnant
- People who are not able to afford the clinic visits or treatments required by the trial
- People who are unable to give informed consent due to a condition affecting their decision-making ability
- People who have a known allergy to bupivacaine (a local anaesthetic medication)
- People who are unable or unwilling to participate in the trial, or who are already taking part in another clinical study at the same time
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Peter Hwang, MD, Stanford University
Phone: (650) 723-5281
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change of Pain Score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.